Dr. Stacy A. S. Killen is an Associate
Professor of Pediatrics in the Division of Pediatric Cardiology at Vanderbilt University Medical Center and the Monroe Carell Jr. Children’s Hospital at
Vanderbilt. She obtained a Bachelor of Arts in English and Biology from Rice University, a Doctorate of Medicine from UT Southwestern Medical School, and a Master of Science in Clinical Investigation from Vanderbilt
University School of Medicine. Dr. Killen completed her pediatrics residency at UT Southwestern and served as a chief resident before completing her pediatric cardiology fellowship and advanced imaging training at Vanderbilt. Her areas of expertise include fetal cardiology, fetal arrhythmias, pediatric cardiology, cardiac imaging, and congenital heart disease. Her clinical and research efforts seek to improve the care of mothers
and fetuses whose pregnancies are complicated by fetal arrhythmias,
including supraventricular tachycardia, long QT syndrome, and SS-A
antibody-mediated congenital heart block. Dr. Killen is currently
participating in several multi-center studies that seek to improve treatment
approaches and outcomes for patients with fetal arrhythmias and complex
congenital heart disease.
Dr. Stacy A. S. Killen is an Associate
Professor of Pediatrics in the Division of Pediatric Cardiology at Vanderbilt University Medical Center and the Monroe Carell Jr. Children’s Hospital at
Vanderbilt. She obtained a Bachelor of Arts in English and Biology from Rice University, a Doctorate of Medicine from UT Southwestern Medical School, and a Master of Science in Clinical Investigation from Vanderbilt
University School of Medicine. Dr. Killen completed her pediatrics residency at UT Southwestern and served as a chief resident before completing her pediatric cardiology fellowship and advanced imaging training at Vanderbilt. Her areas of expertise include fetal cardiology, fetal arrhythmias, pediatric cardiology, cardiac imaging, and congenital heart disease. Her clinical and research efforts seek to improve the care of mothers
and fetuses whose pregnancies are complicated by fetal arrhythmias,
including supraventricular tachycardia, long QT syndrome, and SS-A
antibody-mediated congenital heart block. Dr. Killen is currently
participating in several multi-center studies that seek to improve treatment
approaches and outcomes for patients with fetal arrhythmias and complex
congenital heart disease.